Alex Y. C. Chang
- Oncology
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Cancer Research
- Pathology and Forensic Medicine
- Co-authors
- Peter C. KengJohn M. BennettP. A. BourneD C TormeyAthanasios MantalarisP.C. KengJiangbin WuRaman Qazi
- Topics
- Cancer Treatment and Pharmacology (7 papers)Lung Cancer Research Studies (7 papers)Cancer therapeutics and mechanisms (7 papers)
- Cited by
- OncologyCancer ResearchHematology
- Partner nations
- United StatesMacaoSingapore
In The Last Decade
Alex Y. C. Chang
27 papers receiving 420 citations
Peers
Comparison fields: 5 of 80
- Oncology 177
- Molecular Biology 133
- Pulmonary and Respiratory Medicine 93
- Cancer Research 65
- Pathology and Forensic Medicine 56
Countries citing papers authored by Alex Y. C. Chang
This map shows the geographic impact of Alex Y. C. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Y. C. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Y. C. Chang more than expected).
Fields of papers citing papers by Alex Y. C. Chang
This network shows the impact of papers produced by Alex Y. C. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Y. C. Chang. The network helps show where Alex Y. C. Chang may publish in the future.
Co-authorship network of co-authors of Alex Y. C. Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Alex Y. C. Chang. A scholar is included among the top collaborators of Alex Y. C. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Y. C. Chang. Alex Y. C. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 49 | |
| 3 | 30 | |
| 4 | 39 | |
| 5 | 13 | |
| 6 | In Vitro and Clinical Studies: Paclitaxel and Vinorelbine in Non-Small-Cell Lung Cancer | 2 |
| 7 | PACLITAXEL AND VINORELBINE IN NON-SMALL-CELL LUNG CANCER | 5 |
| 8 | 8 | |
| 9 | 9 | |
| 10 | 1 | |
| 11 | 9 | |
| 12 | 13 | |
| 13 | 5 | |
| 14 | 51 | |
| 15 | Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. | 64 |
| 16 | 7 | |
| 17 | 59 | |
| 18 | Evaluation of vindesine in patients with refractory small cell lung cancer. | 2 |
| 19 | 11 | |
| 20 | Vindesine sulfate (VND): A phase II trial in small cell bronchogenic carcinoma (SCCL) | 2 |
About Alex Y. C. Chang
Alex Y. C. Chang is a scholar working on Neuropsychology and Physiological Psychology, Oncology and Geriatrics and Gerontology, having authored 27 papers that have together received 437 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Lung Cancer Research Studies (7 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Oncology (177 citations), Cancer Research (65 citations) and Hematology (39 citations). Alex Y. C. Chang has collaborated with scholars based in United States, Macao and Singapore. Frequent co-authors include Peter C. Keng, John M. Bennett, P. A. Bourne, D C Tormey, Athanasios Mantalaris, P.C. Keng, Jiangbin Wu, Raman Qazi, Ronald H. Blum and T. E. Davis. Their work appears in journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.